Skip to content

Baxter International BAX Additional Paid-In Capital

Additional Paid-In Capital at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$1.98B+2.1%
Medtronic logo
MedtronicMDT
$20.93B+0.4%
Medline, Inc.
 logo
Medline, Inc. MDLN
$11.13B
Solventum logo
SolventumSOLV
$3.9B+3.0%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$1.96B+4.5%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$0-100%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's additional paid-in capital?
Baxter International (BAX) reported additional paid-in capital of $6.21B in Q1 2026.
How has Baxter International's additional paid-in capital changed year-over-year?
Baxter International's additional paid-in capital decreased by 1.5% year-over-year, from $6.31B to $6.21B.
What is the long-term trend for Baxter International's additional paid-in capital?
Over 5 years (2020 to 2025), Baxter International's additional paid-in capital has grown at a 1.1% compound annual growth rate (CAGR), from $6.04B to $6.37B.
What does additional paid-in capital mean?
The extra money investors paid for shares above their par value.
How do you interpret additional paid-in capital?
Increases reflect successful equity capital raises or stock-based compensation activity.
How does additional paid-in capital compare across companies?
Standard across all public companies; reflects historical equity issuance activity.